CoChat

Consensus paper of the WFSBP Task Force on Biological Markers: Criteria for biomarkers and endophenotypes of schizophrenia, part III: Molecular mechanisms

Open access
Schmitt, Andrea, Martins-de-Souza, Daniel, Akbarian, Schahram, Cassoli, Juliana S., Ehrenreich, Hannelore, Fischer, Andre, Fonteh, Alfred, Gattaz, Wagner F., Gawlik, Michael, Gerlach, Manfred, Grünblatt, Edna, Halene, Tobias, Hasan, Alkomiet, Hashimoto, Kenij, Kim, Yong-Ku, Kirchner, Sophie-Kathrin, Kornhuber, Johannes, Kraus, Theo F.J., Malchow, Berend, Nascimento, Juliana M., Rossner, Moritz, Schwarz, Markus, Steiner, Johann, Talib, Leda, Thibaut, Florence, Riederer, Peter, Falkai, Peter, The Members of the WFSBP Task Force on Biological Markers · 2017 · The World Journal of Biological Psychiatry
Cited by 38

The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.

Abstract

OBJECTIVES: Despite progress in identifying molecular pathophysiological processes in schizophrenia, valid biomarkers are lacking for both the disease and treatment response. METHODS: This comprehensive review summarises recent efforts to identify molecular mechanisms on the level of protein and gene expression and epigenetics, including DNA methylation, histone modifications and micro RNA expression. Furthermore, it summarises recent findings of alterations in lipid mediators and highlights inflammatory processes. The potential that this research will identify biomarkers of schizophrenia is discussed. RESULTS: Recent studies have not identified clear biomarkers for schizophrenia. Although several molecular pathways have emerged as potential candidates for future research, a complete understanding of these metabolic pathways is required to reveal better treatment modalities for this disabling condition. CONCLUSIONS: Large longitudinal cohort studies are essential that pair a thorough phenotypic and clinical evaluation for example with gene expression and proteome analysis in blood at multiple time points. This approach might identify biomarkers that allow patients to be stratified according to treatment response and ideally also allow treatment response to be predicted. Improved knowledge of molecular pathways and epigenetic mechanisms, including their potential association with environmental influences, will facilitate the discovery of biomarkers that could ultimately be effective tools in clinical practice.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1080/15622975.2016.1224929

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 52 references

Cited by

See all 38

Metadata

Authors
Schmitt, A., Martins-de-Souza, D., Akbarian, S., Cassoli, J. S., Ehrenreich, H., Fischer, A., Fonteh, A., Gattaz, W. F., Gawlik, M., Gerlach, M., Grünblatt, E., Halene, T., Hasan, A., Hashimoto, K., Kim, Y.-K., Kirchner, S.-K., Kornhuber, J., Kraus, T. F. J., Malchow, B., Nascimento, J. M., Rossner, M., Schwarz, M., Steiner, J., Talib, L., Thibaut, F., Riederer, P., Falkai, P., & The Members of the WFSBP Task Force on Biological Markers
Venue
The World Journal of Biological Psychiatry
Published
2016-10-26
Volume
18
Issue
5
Pages
330-356
ISSN
  • 1562-2975 (ISSN-L)
  • 1814-1412
OpenAlex
W2539480257
Cited by
38
References
52
FWCI
5.69
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Consensus paper of the WFSBP Task Force on Biological Markers: Criteria for biomarkers and endophenotypes of schizophrenia, part III: Molecular mechanisms. https://app.cochat.ai/papers/10.1080/15622975.2016.1224929
The paper
Schmitt, A., Martins-de-Souza, D., Akbarian, S., Cassoli, J. S., Ehrenreich, H., Fischer, A., Fonteh, A., Gattaz, W. F., Gawlik, M., Gerlach, M., Grünblatt, E., Halene, T., Hasan, A., Hashimoto, K., Kim, Y.-K., Kirchner, S.-K., Kornhuber, J., Kraus, T. F. J., Malchow, B., . . . The Members of the WFSBP Task Force on Biological Markers. (2017). Consensus paper of the WFSBP Task Force on Biological Markers: Criteria for biomarkers and endophenotypes of schizophrenia, part III: Molecular mechanisms. The World Journal of Biological Psychiatry. https://doi.org/10.1080/15622975.2016.1224929

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.